InsiderLens
All transactionsBrowse millions of insider transactions
Top buysLargest insider purchases
Top sellsLargest insider sales
Cluster activityMultiple insiders trading together
All companiesBrowse all 22,000+ companies
ScreenerFilter by sector, country, activity
By countryBrowse by market
All InsidersBrowse all 240,000+ Insiders
Most activeInsiders with the most trades
Best performersHighest returns on insider buys
Alerts

Global search

Find a company or insider, or run a shortcut.

InsiderLens

Track insider trading activity, analyze financial data, and monitor insider transactions across global markets.

Transactions

  • Top buys
  • Top sells
  • Companies
  • Insiders
  • Screener

Resources

  • API
  • Blog
  • Help center
  • Methodology

Company

  • About
  • Contact
  • Privacy policy
  • Terms of service
  • Cookie policy

Data sources: SEC EDGAR (US) · AMF / BDIF (FR) · BaFin (DE) · FCA (GB) · FSMA (BE) · AFM (NL) · CNMV (ES) · SIX (CH) · FI (SE) · Oslo Børs (NO) · Nasdaq Nordic & Baltic · and 20+ other European regulators.

The information provided on InsiderLens is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Insider transaction data is sourced from public regulatory filings. Past insider transactions do not guarantee future performance. Always consult a qualified financial advisor before making investment decisions.

© 2026 InsiderLens

  1. Home
  2. /
  3. Insiders
  4. /
  5. Thomas Stephen Basil

Thomas Stephen Basil

BalancedInformative
BoardEliem Therapeutics, Inc.CIK 0002027962
10 transactions·1 company·Last Aug 7, 2025
39
Score
$00 buys
$00 sells
50%/50%305K shares held ≈ $941K

ELYMEliem Therapeutics, Inc.

BOARD MEMBERatEliem Therapeutics, Inc.ELYM

Last filing: Apr 2026

Also at Eliem Therapeutics, Inc.

AR
Azelby Robert
CEO73 tx
BA
Brennan Aoife
CEO56 tx
AS
ALTSCHULLER Susan
CFO17 tx
LE
Lavelle Erin
CFO11 tx
PE
Pimblett Emily
C SUITE18 tx

Insider transactions by Thomas Stephen Basil

10 transactions — - in purchases, - in sales

DateViaCompanyTypeSharesValue
Aug 7, 25DirectELYMEliem Therapeutics, Inc.Grant100 375-
Jun 27, 25DirectELYMEliem Therapeutics, Inc.Exercise25 094-
Jun 27, 25DirectELYMEliem Therapeutics, Inc.Exercise25 094-
Jun 4, 25DirectELYMEliem Therapeutics, Inc.Grant40 000-
Mar 27, 25DirectELYMEliem Therapeutics, Inc.Exercise25 093-
Mar 27, 25DirectELYMEliem Therapeutics, Inc.Exercise25 093-
Jan 1, 25DirectELYMEliem Therapeutics, Inc.Exercise50 188-
Jan 1, 25DirectELYMEliem Therapeutics, Inc.Exercise50 188-
Jun 27, 24DirectELYMEliem Therapeutics, Inc.Grant100 375-
Jun 27, 24DirectELYMEliem Therapeutics, Inc.Grant103 907-
Direct = personal transaction
Via entity / trust / associate

Frequently asked questions about Thomas Stephen Basil

What are Thomas Stephen Basil's recent insider transactions?

Thomas Stephen Basil has filed 10 insider transactions across 1 company, totaling $0 in purchases and $0 in sales. The most recent filing was on August 7, 2025.

Is Thomas Stephen Basil a net buyer or seller of shares?

Based on regulatory disclosures, Thomas Stephen Basil is a net seller with 0 purchases and 0 sales on record.

Data sourced from public regulatory filings (SEC EDGAR, AMF, BaFin). This information is provided for educational purposes and does not constitute investment advice, a recommendation, or a solicitation to buy or sell securities.

Updated August 7, 2025·Full disclaimer